Expand VNDA Menu
VNDA MENU

VNDA Stock Posts


VNDA #VandaPharmaceuticals stock increases 13.7% after hours.

After Hours Gainer

VNDA Vanda Pharmaceuticals5.03-0.14-2.7%

After Hours:5.72+0.69 (+13.7%)

Vanda Pharmaceuticals Announces Positive Phase III Results for HETLIOZ(tasimelteon) in Delayed Sleep-Wake Phase Disorder

PRNewswireTue, 29-Sep 6:46 PM
VNDA #VandaPharmaceuticals stock increases 27.9% after hours.

After Hours Gainer

VNDA Vanda Pharmaceuticals5.03-0.14-2.7%

After Hours:6.43+1.40 (+27.9%)

Vanda Pharmaceuticals Announces Positive Phase III Results for HETLIOZ(tasimelteon) in Delayed Sleep-Wake Phase Disorder

PRNewswireTue, 29-Sep 6:46 PM
Unusual Option Volume

VNDA Vanda Pharmaceuticals5.36-0.02 (-0.4%)

Vanda Pharmaceuticals trades 2,558 contracts. The company has the following event: on Dec 12, 2026.
View Details...
Upcoming Earnings

VNDA Vanda Pharmaceuticals5.35+0.02 (+0.4%)

Vanda Pharmaceuticals will report earnings after the market closes. View Calendar The market is expecting a ±11.6% move after earnings are reported. The average move for the past 4 quarters of earnings has been ±15.2%. View Expected Move (Conf Call: Aug 5 4:30 PM)
VNDA #VandaPharmaceuticals stock increases 5.3% after hours.

After Hours Gainer

VNDA Vanda Pharmaceuticals5.45-0.40-6.8%

After Hours:5.74+0.29 (+5.3%)

Vanda Pharmaceuticals Announces EMA Positive Opinion for Orphan Drug Designation of Imsidolimab for Generalized Pustular Psoriasis - A Milestone Recognition of GPP as a Distinct Rare Disease in Europe

PRNewswireThu, 16-Jul 4:30 PM
Upcoming Earnings

VNDA Vanda Pharmaceuticals7.52+0.13 (+1.8%)

Vanda Pharmaceuticals will report earnings after the market closes. View Calendar The market is expecting a ±9.0% move after earnings are reported. The average move for the past 4 quarters of earnings has been ±12.6%. View Expected Move (Conf Call: May 6 4:30 PM)
Load Earlier Posts
Market Data Delayed 15 Minutes